Cargando…
CUR5g, a novel autophagy inhibitor, exhibits potent synergistic anticancer effects with cisplatin against non-small-cell lung cancer
Autophagy, a highly conserved degradation process of eukaryotic cells, has been proven to be closely related to chemoresistance and metastasis of non-small-cell lung cancer (NSCLC). Autophagy inhibitors, such as chloroquine (CQ) and its derivative hydroxychloroquine (HCQ), has been shown to mediate...
Autores principales: | Chen, Jingxuan, Shen, Yunpeng, Wu, Bowen, Yang, Peichang, Sun, Gangchun, Liu, Xiaoting, Qiang, Pengfei, Gao, Yamei, Sha, Fangfang, Li, Zirui, Zhang, Lu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9622744/ https://www.ncbi.nlm.nih.gov/pubmed/36316321 http://dx.doi.org/10.1038/s41420-022-01217-9 |
Ejemplares similares
-
Identification of Compound CB-2 as a Novel Late-Stage Autophagy Inhibitor Exhibits Inhibitory Potency against A549 Cells
por: Liu, Zhihui, et al.
Publicado: (2021) -
Inetetamab, a novel anti-HER2 monoclonal antibody, exhibits potent synergistic anticancer effects with cisplatin by inducing pyroptosis in lung adenocarcinoma
por: Cui, Jinfang, et al.
Publicado: (2023) -
CD44 connects autophagy decline and ageing in the vascular endothelium
por: Zhang, Lu, et al.
Publicado: (2023) -
Berberine and Cisplatin Exhibit Synergistic Anticancer Effects on Osteosarcoma MG-63 Cells by Inhibiting the MAPK Pathway
por: Gao, Xianxian, et al.
Publicado: (2021) -
TPGS-1000 exhibits potent anticancer activity for hepatocellular carcinoma in vitro and in vivo
por: Chen, Yidan, et al.
Publicado: (2020)